Six years before the pandemic, fledgling Cambridge biotech Moderna was searching for a way to get its revolutionary RNA technology to work in humans. One of the biggest problems was figuring out how ...

The COVID-19 pandemic has necessitated the rapid development of new technologies for vaccine development and delivery. One key development has stemmed from the need for largescale production of ...

BERLIN--(BUSINESS WIRE)--Bayer AG is joining forces with Acuitas Therapeutics, Inc., a biotechnology company specializing in the development of lipid nanoparticle (LNP) delivery systems for molecular ...

Certest Pharma specializes in advanced lipid nanoparticle technology, focusing on the development of effective and targeted LNPs for next-generation medicines. Certest’s licensable technology includes ...

Michael Mitchell, an associate professor of bioengineering at the University, is developing novel lipid nanoparticles that can deliver mRNA inside human cells, which could pave the way for therapies ...

Under Leshem's leadership, ViVac will accelerate its preclinical oncology pipeline, which includes programs in liver, ovarian ...

Nanoparticles have once again reached the spotlight, this time as a critical tool to combat the spread of covid-19. In this particular case, messenger ribonucleic acid (mRNA) encapsulated in lipid ...

Advances in sequencing technologies have accelerated the discovery of the genetic causation of diseases and new cell types. This revolution has also given rise to a new technique known as genetic ...

Artificial intelligence (AI) is fundamentally reshaping biotechnology and healthcare, unlocking the secrets hidden within ...